Document is current
Any future updates will be listed below
-
Authors
van Beekhuizen, Sophie https://orcid.org/0009-0008-1567-9155
Che, Menglu https://orcid.org/0000-0002-0594-5797
Monfort, Loraine https://orcid.org/0009-0008-2946-1229
Hashim, Mahmoud https://orcid.org/0000-0002-5775-9590
Azough, Ali https://orcid.org/0009-0009-2815-5964
Kubitz, Nicole https://orcid.org/0009-0002-3741-0452
Griffin, Adrian
Price, Martin
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals
- License Information
-
More Information
Article History
Accepted: 19 March 2025
First Online: 22 April 2025
Declarations
:
: The funding for this manuscript was provided by Janssen EMEA, a Johnson & Johnson (J&J) company.
: A.A., A.G., M.H., N.K., and M.P. are employees of J&J. A.A., A.G., M.H., M.P., and N.K. own stock in J&J. L.M. and S.V.B. are employees of Cytel, Inc., a research consultancy. M.C. was employed by Cytel, Inc. at the time of manuscript development.
: All authors contributed to the study conception and design, data collection and analysis, and reporting/writing of this manuscript. All authors have read and approved the final version of this manuscript for submission.
: Not applicable.
: Data are available upon request.
: Not applicable.
: Not applicable.
: Not applicable.
